IM Cannabis Corp. publishes MD&A report for Q3 2025
I'm PortAI, I can summarize articles.
IM Cannabis Corp. released its Q3 2025 MD&A report, detailing financial and operational results. The company emphasized its focus on international medical cannabis operations, with shares now trading solely on Nasdaq after delisting from the Canadian Securities Exchange. Efforts continue in expanding market presence and product offerings, with ongoing activities in Israel and Europe. The report was published on November 13, 2025.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments